The following adverse reactions are described elsewhere in the labeling:
1. Risk of Serious Hepatotoxicity with Concomitant Use of Strong CYP3A Inducers
2. Central Nervous System Effects
3. Hyperlipidemia
4. Atrioventricular Block
5. Interstitial Lung Disease/Pneumonitis
6. Hypertension
7. Hyperglycemia
FDA,2021.03
Lucius Pharmaceutical Co., Ltd., was established in 2020 in Vientiane, the capital of Laos. It aims to offer safe, effective, and affordable medicines globally. With a factory spanning 25,000 square meters, the company manufactures 200+ generic drugs in diverse therapeutic fields.
Address:No.26 Thongmang village, Xaythany district, Vientiane Capital, Laos
E-mail:laoslucius@gmail.com
Whatsapp: